You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site


Go back



Ventolin (salbutamol sulphate) is indicated for the relief of bronchospasm in bronchial asthma of all types, Chronic Bronchitis & Emphysema.

About Ventolin

Open the door to effective relief


Video player requires JavaScript enabled. You can download this video here:

Manufacturing Video

Expert Video

See what the industry experts have to say about Ventolin


  1. Sanders M. Prim Care Respir J 2007;16:71–81.
  2. Ventolin Evohaler Datasheet. Version Number: GDS24/IPI08. Date of Issue: 21st May 2013.
  3. Price AH, et al. Drugs 1989;38:77–122.
  4. GSK Data on File. Document number 2020N433633_00, March 2020.

Adverse Events must be reported. For products related to GSK Pakistan, please report adverse events via email at or call us at +92 (21) 111 475 725 - Ext: 7&8.

Full prescribing information is available on request.
GlaxoSmithKline Pakistan Limited
35 - Dockyard Road, West Wharf, Karachi - 74000.
Ventolin and Evohaler are trademarks of GlaxoSmithKline group of companies. 
GlaxoSmithKline Pakistan Limited is a member of GlaxoSmithKline group of companies.
© 2021 GlaxoSmithKline Pakistan Limited.